BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 6509799)

  • 1. Circulating immune complexes (CIC), carcinoembryonic antigen (CEA) and CIC containing CEA as markers for colorectal cancer.
    Chester KA; Begent RH
    Clin Exp Immunol; 1984 Dec; 58(3):685-93. PubMed ID: 6509799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating immune complexes in patients following clinically curative resection of colorectal cancer.
    Steele G; Sonis S; Stelos P; Rittgers R; Zamcheck N; Finn D; Maltz J; Mayer R; Lokich J; Wilson RE
    Surgery; 1978 Jun; 83(6):648-54. PubMed ID: 205963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical evaluation of CEA in colorectal carcinoma].
    Shimoyama T; Fukuda Y; Itoh S; Shimizu T; Kawaguchi A; Mori M; Ishii T; Miura T; Tomita M
    Gan No Rinsho; 1985 May; 31(6 Suppl):648-54. PubMed ID: 3897618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinoembryonic antigen in patients with colorectal cancer: correlation between stage of disease and antigen level.
    Bartal AH; Ayalon D; Cordova T; Avidan S; Robinson E
    Isr J Med Sci; 1983 Sep; 19(9):801-5. PubMed ID: 6643017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carcinoembryonic antigen (CEA). A prospective clinical trail in patients with gastrointestinal cancer.
    Kjaer M; Fischerman K
    Scand J Gastroenterol Suppl; 1976; 37():99-106. PubMed ID: 1064149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study of the reliability of carcinoembryonic antigen blood levels in following the course of colorectal cancer.
    Armitage NC; Davidson A; Tsikos D; Wood CB
    Clin Oncol; 1984 Jun; 10(2):141-7. PubMed ID: 6375928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are carcinoembryonic antigen levels of value in the curative management of colorectal cancer?
    Wanebo HJ
    Surgery; 1981 Mar; 89(3):290-5. PubMed ID: 7466616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Using CEA for diagnostic, therapeutic and prognostic evaluation in colorectal cancers].
    Terabe K; Ichihashi H; Kamei H; Kondo T
    Gan To Kagaku Ryoho; 1984 Jan; 11(1):111-6. PubMed ID: 6696454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Interest and limits of estimation of the carcinoembryonic antigen in colonic and rectal (author's transl)].
    Arnaud JP; Simon P; Ollier JC; Koehl C; Adloff M
    J Chir (Paris); 1979 Nov; 116(11):633-6. PubMed ID: 555768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative carcinoembryonic antigen and prognosis in patients with colorectal cancer.
    Onetto M; Paganuzzi M; Secco GB; Fardelli R; Santi F; Rovida S; Ferrara GB
    Biomed Pharmacother; 1985; 39(7):392-5. PubMed ID: 3830268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinoembryonic antigen: usefulness as a postsurgical method in the detection of recurrence in Dukes stages B2 and C colorectal cancers.
    Koch M; Washer G; Gaedke H; McPherson TA
    J Natl Cancer Inst; 1982 Oct; 69(4):813-5. PubMed ID: 6956758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carcinoembryonic antigen fraction in digestive cancer.
    Fong S; García Vega G; León V
    Neoplasma; 1985; 32(2):199-208. PubMed ID: 4000309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CEA levels at recurrence and metastases; importance for detecting secondary disease.
    Rieger A; Wahren B
    Scand J Gastroenterol; 1975; 10(8):869-74. PubMed ID: 1202621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoglobulins (Ig) in circulating immune complexes (CIC) in cancer and inflammatory bowel disease (IBD).
    Shafir M; Martinelli G; Bekesi JG; Jaramillo S; Heimann T; Aufses AH
    Eur J Surg Oncol; 1986 Dec; 12(4):351-7. PubMed ID: 3780988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Carcinoembryonic antigen, CEA, in colorectal cancer. An insensitive marker which may be excluded from follow-ups].
    Wählby L
    Lakartidningen; 1997 Apr; 94(18):1716-8. PubMed ID: 9182180
    [No Abstract]   [Full Text] [Related]  

  • 16. [Value and limits of the determination of carcinoembryonic antigen (CEA) in postoperative evaluation of patients with colonic and rectal carcinomas].
    Jaeger P; Pettavel J; Wuilleret B; Bertholet MM; Mach JP
    Schweiz Med Wochenschr; 1975 Nov; 105(46):1533-8. PubMed ID: 1220002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carcinoembryonic antigen: 3 years' experience in a cancer clinic.
    Koch M; McPherson TA; Morrish DW
    Can Med Assoc J; 1977 Apr; 116(7):769-71. PubMed ID: 849560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of combined CA-19-9 and CEA assay in monitoring recurrences and metastases of colorectal cancer].
    Yu BM
    Zhonghua Wai Ke Za Zhi; 1992 Dec; 30(12):707-9, 777. PubMed ID: 1339738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum CEA in the follow-up of colorectal carcinoma: experience in a district general hospital.
    Allen-Mersh TG
    Ann R Coll Surg Engl; 1984 Jan; 66(1):14-6. PubMed ID: 6691692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical applications of the carcinoembryonic antigen (CEA) determination in colorectal cancer (observations of 119 cases)].
    Sivelli R; Farinon AM; Chiampo L
    Chir Ital; 1980 Oct; 32(5):946-63. PubMed ID: 6166402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.